The role of cognitive behavioural therapy in living well with COPD by Heslop-Marshall K & Burns G
95https://doi.org/10.1183/20734735.0119-2019 Breathe | June 2019 | Volume 15 | No 2
@ERSpublications
Psychological ill health is very common in COPD; CBT may be a key step towards improving the care 
of COPD patients http://ow.ly/fb8j30onfPj
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Editorial
The role of cognitive behavioural 
therapy in living well with COPD
The objectives of this editorial are to explore the 
importance of psychological comorbidity in chronic 
obstructive pulmonary disease (COPD), potential 
treatment options and why clinicians do not address 
this important issue.
COPD is a common, progressive respiratory 
condition, affecting millions of people worldwide [1]. 
At an individual level COPD often leads to gradual 
progressive breathlessness and disability, punctuated 
by episodes of worsening of symptoms. These 
exacerbations are often life threatening, necessitating 
admission to hospital. The principal physiological 
abnormality is airway obstruction. Traditionally the 
mainstay of treatment has been inhaled medication, 
aimed at reducing that obstruction, and vast sums 
of money are spent on inhalers globally every 
year. While inhaled medication has an important 
role, there is now increasing recognition of the 
importance of non-respiratory manifestations of 
COPD including: fatigue, malaise, muscle wasting, 
reduced appetite, weight loss, osteoporosis, anxiety 
and depression. Recent national and international 
guidelines recognise that good quality, holistic care of 
COPD should address all aspects of the condition and 
not merely focus on treatments aimed at improving 
airway obstruction [1–3].
Until recently one of the most important aspects 
of COPD, its psychological impact, was barely 
recognised, let alone, addressed [4, 5]. Psychological 
ill health is very common in COPD: ∼60% of patients 
with COPD have symptoms of anxiety and 40% have 
symptoms of depression [6]. Anxiety and depression 
have a significant impact on breathlessness, physical 
functioning, quality of life, exacerbation rates, use 
of healthcare resources, length of hospital stay, 
readmission rates and mortality [7–10]. Both 
anxiety and depression are, of course, enormously 
detrimental to quality of life in their own right; they 
also interact with and amplify physical symptoms of 
COPD. Hyperventilation and panic can heighten the 
sensation of breathlessness [11] and a vicious cycle 
can develop. Patients with psychological difficulties 
are less able to manage symptoms [12], are less 
likely to be physically active [13] or attend pulmonary 
rehabilitation, an evidence based intervention, 
which is a key strategy for people with chronic 
respiratory conditions [14]. However, if recognised, 
the psychological impact of COPD is very treatable.
How can we treat 
psychological 
difficulties in COPD?
For many years the integration of physical and 
mental health has been poor. Recent studies have 
demonstrated the value of psychological therapy, 
with promising results for cognitive behavioural 
therapy (CBT) in the treatment of anxiety and 
depression in COPD [10, 15, 16]. CBT is an evidence-
based, patient-centred, individualised, structured 
psychological treatment, which aims to understand 
patients’ current difficulties. CBT explores the 
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links between a patient’s situation, physical 
symptoms, thoughts, emotions and behaviour 
[17, 18]. Techniques are directed at tackling 
current difficulties and teaching the patient skills 
to identify unhelpful thinking or behaviour which 
might be causing vicious cycles of anxiety and/or 
depression. Having a clearer understanding of the 
patient’s problems can then lead to identifying ways 
to overcome these difficulties and identify strategies 
that can help improve the patient’s quality of life.
A starting point for patients with respiratory 
problems is to identify what triggers a patient’s 
breathlessness: physical (e.g. exertion) and/or 
psychological factors (fear or panic). You can then 
work with the patient to develop a self-management 
plan to address their physical and psychological 
difficulties [19]. Many cognitive and behavioural 
techniques enhance medical care, for example, 
identifying and addressing unhelpful thinking (e.g. I 
need oxygen because I am breathless), planning and 
pacing activities, breathing techniques, distraction 
and relaxation can all help breathlessness alongside 
inhaled therapy. Recently, a large randomised 
controlled trial of CBT in COPD found that respiratory 
nurses were able to learn and deliver CBT techniques 
as a brief intervention to patients with COPD and 
that this improved symptoms of anxiety and reduced 
use of healthcare resources (emergency department 
attendance and hospital admissions) [20, 21].
Due to the high level of psychological comorbidity, 
at the very least, healthcare professionals need to 
be able to identify when patients have psychological 
difficulties and know when to refer on. Patients with all 
levels of COPD severity and symptoms of anxiety and/
or depression can benefit from CBT [20]. It is crucially 
important that clinicians are working at a level within 
their competency skills. It is important to know when 
it is appropriate for appropriately trained respiratory 
healthcare professionals to undertake CBT and when 
it is not. To provide safe and effective psychological 
care we must ensure that the right person with the 
right skills is providing the treatment. For patients 
with mild to moderate symptoms of anxiety or 
depression then it is clearly feasible for appropriately 
trained respiratory healthcare professionals to provide 
a brief CBT intervention [20]. However, for patients 
with moderate to severe symptoms or those with 
symptoms indicative of psychiatric disorders, such as 
generalised anxiety, post-traumatic stress disorder or 
obsessive compulsive disorder, then referral to mental 
health services will be required [22]. Unfortunately, 
clinicians often avoid addressing the issue at all.
So why is it taking so 
long for clinicians to 
address this issue?
Three barriers are identifiable. First, there is 
probably a failure to recognise the scale of the 
problem. Doctors might have observed evident 
symptoms of anxiety in a few cases and assumed the 
problem related to the psychological makeup of the 
individual. Yet a moment’s reflection in anyone with 
even a basic understanding of the human condition 
would have led to the acknowledgement that being 
“unable to breathe” is one of the most frightening 
and panic-inducing events a human being can 
experience. Patients (if you care to ask them about it) 
will tell you they can feel as if they “are about to die”. 
Panic is understandably common during episodes 
of severe breathlessness. In fact, the prevalence of 
panic disorder in patients with COPD is up to 10 
times greater than the overall population prevalence 
and panic attacks are commonly experienced [23].
Secondly, there has been a lack of acceptance that, 
as clinicians looking after COPD patients, the issue 
of psychological ill health was part of our remit. It is 
not simply that we did not feel we had the requisite 
skill set to deal with the problem, we perhaps felt 
that the outcomes of treatment, e.g. reduced levels 
of anxiety, were the concern of others and bore no 
relationship to the outcomes we were interested in: 
reducing breathlessness and hospital admission. 
However, CBT has now been shown to reduce anxiety 
and breathlessness [10, 21] and admissions [20].
Thirdly, the final barrier is one of access to 
the appropriate therapy as availability of trained 
therapists is scarce. Given the shortage of 
psychologists, the model for delivering psychological 
care, in the form of CBT, to respiratory patients 
described by Heslop-Marshall et al. [20] in their 
real-world study would seem not only opportune 
but apposite. If CBT skills could be acquired by 
respiratory clinicians (nurses, physiotherapists 
or even doctors) it could create a super-therapist 
with a highly relevant suite of knowledge and skills 
to integrate physical and psychological care in a 
truly holistic way; a therapist, perhaps uniquely 
placed to not only deal with the separate issues of 
physical symptoms, such as breathlessness, and 
psychological symptoms, such as anxiety, but also 
to understand their relationship to one another and 
begin the untangling process.
Conclusion
Front-line clinicians are often aware that patients 
experience symptoms of anxiety and depression. 
After all, we’d all acknowledge that breathlessness 
is a very frightening symptom that most respiratory 
patients experience. What has hitherto been 
unrecognised is that addressing psychological 
distress will also help achieve important physical 
outcomes, such as reduced breathlessness and 
fewer hospital admissions.
There is increasing evidence that integrating 
mental and physical care for people with long-term 
conditions can improve both physical and mental 
health and reduce costs [24]. The question of how to 
incorporate CBT into routine care has been addressed 
in a real-world study [8]. My colleagues and I have 
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demonstrated that it is feasible to train respiratory 
nurses to deliver CBT for patients. This care model 
brings significant benefits to patients and cost 
savings to healthcare services [20]. As Yohannes [8] 
has suggested, CBT may be a key step towards 
improving the care of COPD patients. The challenge 
facing clinicians, managers and commissioners is 
to implement this model into routine clinical care 
and have a clear pathway to refer more complex 
psychological problems on to mental health teams.
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